5-Amino-1MQ · A small molecule, not a peptide, in preclinical research

5-Amino-1MQ is a small synthetic molecule (not a peptide) that inhibits the enzyme NNMT, which is involved in cellular energy metabolism. It is discussed in metabolic and body-composition contexts because of mouse studies published from around 2018.

There are no published human trials. It is included here because it is sold in the same channels as peptides and people ask.

In mouse models, NNMT inhibition altered fat-cell metabolism and reduced fat mass. Whether the mechanism operates the same way in humans, and at what safety cost, is unknown.

In the United States this compound is not an FDA-approved drug for any use. It is not lawfully sold for human use as a "research chemical", and whether a licensed provider can consider it depends on federal compounding rules and state law, both of which change. This is a general note, not legal advice.